Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bergmann

Showing results (231-240 of 350) with videos related to

Pageof 35
Sort By:
La Revue De Medecine Interne|May 24, 2014
[What happens to therapeutic changes decided during hospitalization in an internal medicine ward? A two-month single-centre prospective study in France]M Coutellier, S Mouly, V Delcey, et al.
Klinische Padiatrie|March 2, 2016
Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with NeuroblastomaA Pohl, M Erichsen, M Stehr, et al.
Therapie|March 1, 1987
[Priapism during treatment with calcium heparinate]J F Bergmann, P Fava, M O Bitker, et al.
Journal Des Maladies Vasculaires|February 24, 2004
[New biological markers for acute coronary artery disease]C Meune, E Martins, Y Fulla, et al.
Gastroenterologie Clinique Et Biologique|February 1, 1986
[Sclerosing cholangitis after chemotherapy by continuous hepatic intra-arterial infusion of fluorodeoxyuridine]J F Bergmann, P Rougier, C Liguory, et al.
Presse Medicale (Paris, France : 1983)|June 6, 1992
[Prevention of gastroduodenal lesions induced by non-steroidal anti-inflammatory agents. Economic analysis from a survey of 356 physicians]J F Bergmann, L Pichot, G de Pouvourville, et al.
Cancer|January 15, 1987
Elevation of CA 125 in patients with benign and malignant ascitesJ F Bergmann, J M Bidart, M George, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1992
Effects of acetorphan, an antidiarrhoeal enkephalinase inhibitor, on oro-caecal and colonic transit times in healthy volunteersJ F Bergmann, S Chaussade, D Couturier, et al.
Clinical Pharmacology and Therapeutics|April 1, 1995
Orocecal transit time in humans assessed by sulfapyridine appearance in saliva after sulfasalazine intakeR Dhôte, J F Bergmann, P Leglise, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1994
Safety of alternating ganciclovir and foscarnet maintenance therapy in human immunodeficiency virus (HIV)-related cytomegalovirus infections. An open-labeled pilot studyM Peters, D Schürmann, F Bergmann, et al.
Pageof 35

Showing results (231-240 of 350) with videos related to

Sort By:
Pageof 35
La Revue De Medecine Interne|May 24, 2014
[What happens to therapeutic changes decided during hospitalization in an internal medicine ward? A two-month single-centre prospective study in France]M Coutellier, S Mouly, V Delcey, et al.
Klinische Padiatrie|March 2, 2016
Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with NeuroblastomaA Pohl, M Erichsen, M Stehr, et al.
Therapie|March 1, 1987
[Priapism during treatment with calcium heparinate]J F Bergmann, P Fava, M O Bitker, et al.
Journal Des Maladies Vasculaires|February 24, 2004
[New biological markers for acute coronary artery disease]C Meune, E Martins, Y Fulla, et al.
Gastroenterologie Clinique Et Biologique|February 1, 1986
[Sclerosing cholangitis after chemotherapy by continuous hepatic intra-arterial infusion of fluorodeoxyuridine]J F Bergmann, P Rougier, C Liguory, et al.
Presse Medicale (Paris, France : 1983)|June 6, 1992
[Prevention of gastroduodenal lesions induced by non-steroidal anti-inflammatory agents. Economic analysis from a survey of 356 physicians]J F Bergmann, L Pichot, G de Pouvourville, et al.
Cancer|January 15, 1987
Elevation of CA 125 in patients with benign and malignant ascitesJ F Bergmann, J M Bidart, M George, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1992
Effects of acetorphan, an antidiarrhoeal enkephalinase inhibitor, on oro-caecal and colonic transit times in healthy volunteersJ F Bergmann, S Chaussade, D Couturier, et al.
Clinical Pharmacology and Therapeutics|April 1, 1995
Orocecal transit time in humans assessed by sulfapyridine appearance in saliva after sulfasalazine intakeR Dhôte, J F Bergmann, P Leglise, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1994
Safety of alternating ganciclovir and foscarnet maintenance therapy in human immunodeficiency virus (HIV)-related cytomegalovirus infections. An open-labeled pilot studyM Peters, D Schürmann, F Bergmann, et al.
Pageof 35